glp-1 drugs canada Exclusive-Cigna drops coverage of obesity for its own employees Weight Loss Medication in Canada:

They are ideal for patients looking for sustainable, ongoing support rather than a quick fix

D., Sutton, K

21 Headache outcomes may show more benefit over a longer trial duration, as during the relatively short time horizon of this trial other factors may also have contributed to headache such as medication overuse and opiate use, which occur in approximately one-third of IIH patients

The other long-term concern is muscle loss (sarcopenia), which is not drug specific it accompanies any form of rapid weight reduction, and needs preventive measures like enhanced protein intake and strength training to be instituted from the beginning